Company intelligence / Profile preview

FILLMED

Ownership: Private
Employees: ~289
Development stage: Commercial

Overview

FILLMED’s products—including ART FILLER® hyaluronic acid injectables and NCTF® solutions—are commercially available worldwide. Clinical studies have demonstrated efficacy in wrinkle reduction, volume restoration, skin hydration improvement, and overall rejuvenation. The ART FILLER® range uses Tri-Hyal® technology for optimal results; NCTF® has been clinically validated for improving fine lines and skin quality over an extended period.

Therapeutic areas: Dermatology
Modalities: Hyaluronic acid gel (Biologic)Chemical peel (Small molecule/Device)Cosmetic skincare products (Non-pharmacological therapy/Cosmetic)Injectable solution with vitamins and amino acids (Biologic/Small molecule combination)
Industry: Therapeutic Medical Devices

Drug pipeline

2 assets

NCTF 135 HA

Commercial

Indications: Skin rejuvenation, Fine lines

1 more asset in the full pipeline.

Request access →

Partnerships

Crescita Therapeutics Inc. (exclusive Canadian distributor)

Beyond the preview

Go deeper on FILLMED.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FILLMED.

Explore the full profile